The global Engineered T Cells market was valued at US$ 270.8 million in 2022 and is projected to reach US$ 1308.3 million by 2029, at a CAGR of 25.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Engineered T Cell market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Engineered T Cell market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Engineered T Cell market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Engineered T Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Engineered T Cells. This report contains market size and forecasts of Engineered T Cells in global, including the following market information:
Global Engineered T Cells Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tumor Infiltrating Lymphocytes Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Engineered T Cells include Autolus Limited, Bellicum Pharmaceuticals, Cells Medica, Elli Lilly and Company, Gilead Sciences, Juno Therapeutics, Novartis, Oxford Biomedica and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Engineered T Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Engineered T Cells Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Engineered T Cells Market Segment Percentages, by Type, 2022 (%)
- Tumor Infiltrating Lymphocytes
- T Cell Receptor {TCR}
- Chimeric Antigen Receptor(CAR)
Global Engineered T Cells Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Engineered T Cells Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Cancer Research Centers
- Clinics
Global Engineered T Cells Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Engineered T Cells Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Engineered T Cells revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Engineered T Cells revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Autolus Limited
- Bellicum Pharmaceuticals
- Cells Medica
- Elli Lilly and Company
- Gilead Sciences
- Juno Therapeutics
- Novartis
- Oxford Biomedica
- Pfizer
- Precision Bioscience
- Redmile Group
- Seeking Alpha
- Unum Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Engineered T Cells, market overview.
Chapter 2: Global Engineered T Cells market size in revenue.
Chapter 3: Detailed analysis of Engineered T Cells company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Engineered T Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Engineered T Cells Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Engineered T Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Engineered T Cells Overall Market Size
2.1 Global Engineered T Cells Market Size: 2022 VS 2032
2.2 Global Engineered T Cells Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Engineered T Cells Players in Global Market
3.2 Top Global Engineered T Cells Companies Ranked by Revenue
3.3 Global Engineered T Cells Revenue by Companies
3.4 Top 3 and Top 5 Engineered T Cells Companies in Global Market, by Revenue in 2022
3.5 Global Companies Engineered T Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Engineered T Cells Players in Global Market
3.6.1 List of Global Tier 1 Engineered T Cells Companies
3.6.2 List of Global Tier 2 and Tier 3 Engineered T Cells Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Engineered T Cells Market Size Markets, 2022 & 2032
4.1.2 Tumor Infiltrating Lymphocytes
4.1.3 T Cell Receptor {TCR}
4.1.4 Chimeric Antigen Receptor(CAR)
4.2 By Type - Global Engineered T Cells Revenue & Forecasts
4.2.1 By Type - Global Engineered T Cells Revenue, 2018-2023
4.2.2 By Type - Global Engineered T Cells Revenue, 2024-2032
4.2.3 By Type - Global Engineered T Cells Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Engineered T Cells Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Cancer Research Centers
5.1.4 Clinics
5.2 By Application - Global Engineered T Cells Revenue & Forecasts
5.2.1 By Application - Global Engineered T Cells Revenue, 2018-2023
5.2.2 By Application - Global Engineered T Cells Revenue, 2024-2032
5.2.3 By Application - Global Engineered T Cells Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Engineered T Cells Market Size, 2022 & 2032
6.2 By Region - Global Engineered T Cells Revenue & Forecasts
6.2.1 By Region - Global Engineered T Cells Revenue, 2018-2023
6.2.2 By Region - Global Engineered T Cells Revenue, 2024-2032
6.2.3 By Region - Global Engineered T Cells Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Engineered T Cells Revenue, 2018-2032
6.3.2 US Engineered T Cells Market Size, 2018-2032
6.3.3 Canada Engineered T Cells Market Size, 2018-2032
6.3.4 Mexico Engineered T Cells Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Engineered T Cells Revenue, 2018-2032
6.4.2 Germany Engineered T Cells Market Size, 2018-2032
6.4.3 France Engineered T Cells Market Size, 2018-2032
6.4.4 U.K. Engineered T Cells Market Size, 2018-2032
6.4.5 Italy Engineered T Cells Market Size, 2018-2032
6.4.6 Russia Engineered T Cells Market Size, 2018-2032
6.4.7 Nordic Countries Engineered T Cells Market Size, 2018-2032
6.4.8 Benelux Engineered T Cells Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Engineered T Cells Revenue, 2018-2032
6.5.2 China Engineered T Cells Market Size, 2018-2032
6.5.3 Japan Engineered T Cells Market Size, 2018-2032
6.5.4 South Korea Engineered T Cells Market Size, 2018-2032
6.5.5 Southeast Asia Engineered T Cells Market Size, 2018-2032
6.5.6 India Engineered T Cells Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Engineered T Cells Revenue, 2018-2032
6.6.2 Brazil Engineered T Cells Market Size, 2018-2032
6.6.3 Argentina Engineered T Cells Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Engineered T Cells Revenue, 2018-2032
6.7.2 Turkey Engineered T Cells Market Size, 2018-2032
6.7.3 Israel Engineered T Cells Market Size, 2018-2032
6.7.4 Saudi Arabia Engineered T Cells Market Size, 2018-2032
6.7.5 UAE Engineered T Cells Market Size, 2018-2032
7 Engineered T Cells Companies Profiles
7.1 Autolus Limited
7.1.1 Autolus Limited Company Summary
7.1.2 Autolus Limited Business Overview
7.1.3 Autolus Limited Engineered T Cells Major Product Offerings
7.1.4 Autolus Limited Engineered T Cells Revenue in Global Market (2018-2023)
7.1.5 Autolus Limited Key News & Latest Developments
7.2 Bellicum Pharmaceuticals
7.2.1 Bellicum Pharmaceuticals Company Summary
7.2.2 Bellicum Pharmaceuticals Business Overview
7.2.3 Bellicum Pharmaceuticals Engineered T Cells Major Product Offerings
7.2.4 Bellicum Pharmaceuticals Engineered T Cells Revenue in Global Market (2018-2023)
7.2.5 Bellicum Pharmaceuticals Key News & Latest Developments
7.3 Cells Medica
7.3.1 Cells Medica Company Summary
7.3.2 Cells Medica Business Overview
7.3.3 Cells Medica Engineered T Cells Major Product Offerings
7.3.4 Cells Medica Engineered T Cells Revenue in Global Market (2018-2023)
7.3.5 Cells Medica Key News & Latest Developments
7.4 Elli Lilly and Company
7.4.1 Elli Lilly and Company Company Summary
7.4.2 Elli Lilly and Company Business Overview
7.4.3 Elli Lilly and Company Engineered T Cells Major Product Offerings
7.4.4 Elli Lilly and Company Engineered T Cells Revenue in Global Market (2018-2023)
7.4.5 Elli Lilly and Company Key News & Latest Developments
7.5 Gilead Sciences
7.5.1 Gilead Sciences Company Summary
7.5.2 Gilead Sciences Business Overview
7.5.3 Gilead Sciences Engineered T Cells Major Product Offerings
7.5.4 Gilead Sciences Engineered T Cells Revenue in Global Market (2018-2023)
7.5.5 Gilead Sciences Key News & Latest Developments
7.6 Juno Therapeutics
7.6.1 Juno Therapeutics Company Summary
7.6.2 Juno Therapeutics Business Overview
7.6.3 Juno Therapeutics Engineered T Cells Major Product Offerings
7.6.4 Juno Therapeutics Engineered T Cells Revenue in Global Market (2018-2023)
7.6.5 Juno Therapeutics Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Engineered T Cells Major Product Offerings
7.7.4 Novartis Engineered T Cells Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Oxford Biomedica
7.8.1 Oxford Biomedica Company Summary
7.8.2 Oxford Biomedica Business Overview
7.8.3 Oxford Biomedica Engineered T Cells Major Product Offerings
7.8.4 Oxford Biomedica Engineered T Cells Revenue in Global Market (2018-2023)
7.8.5 Oxford Biomedica Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Engineered T Cells Major Product Offerings
7.9.4 Pfizer Engineered T Cells Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Precision Bioscience
7.10.1 Precision Bioscience Company Summary
7.10.2 Precision Bioscience Business Overview
7.10.3 Precision Bioscience Engineered T Cells Major Product Offerings
7.10.4 Precision Bioscience Engineered T Cells Revenue in Global Market (2018-2023)
7.10.5 Precision Bioscience Key News & Latest Developments
7.11 Redmile Group
7.11.1 Redmile Group Company Summary
7.11.2 Redmile Group Business Overview
7.11.3 Redmile Group Engineered T Cells Major Product Offerings
7.11.4 Redmile Group Engineered T Cells Revenue in Global Market (2018-2023)
7.11.5 Redmile Group Key News & Latest Developments
7.12 Seeking Alpha
7.12.1 Seeking Alpha Company Summary
7.12.2 Seeking Alpha Business Overview
7.12.3 Seeking Alpha Engineered T Cells Major Product Offerings
7.12.4 Seeking Alpha Engineered T Cells Revenue in Global Market (2018-2023)
7.12.5 Seeking Alpha Key News & Latest Developments
7.13 Unum Therapeutics
7.13.1 Unum Therapeutics Company Summary
7.13.2 Unum Therapeutics Business Overview
7.13.3 Unum Therapeutics Engineered T Cells Major Product Offerings
7.13.4 Unum Therapeutics Engineered T Cells Revenue in Global Market (2018-2023)
7.13.5 Unum Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Engineered T Cells Market Opportunities & Trends in Global Market
Table 2. Engineered T Cells Market Drivers in Global Market
Table 3. Engineered T Cells Market Restraints in Global Market
Table 4. Key Players of Engineered T Cells in Global Market
Table 5. Top Engineered T Cells Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Engineered T Cells Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Engineered T Cells Revenue Share by Companies, 2018-2023
Table 8. Global Companies Engineered T Cells Product Type
Table 9. List of Global Tier 1 Engineered T Cells Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Engineered T Cells Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Engineered T Cells Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Engineered T Cells Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Engineered T Cells Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Engineered T Cells Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Engineered T Cells Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Engineered T Cells Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Engineered T Cells Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Engineered T Cells Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Engineered T Cells Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Engineered T Cells Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Engineered T Cells Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Engineered T Cells Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Engineered T Cells Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Engineered T Cells Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Engineered T Cells Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Engineered T Cells Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Engineered T Cells Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Engineered T Cells Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Engineered T Cells Revenue, (US$, Mn), 2024-2032
Table 30. Autolus Limited Company Summary
Table 31. Autolus Limited Engineered T Cells Product Offerings
Table 32. Autolus Limited Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 33. Autolus Limited Key News & Latest Developments
Table 34. Bellicum Pharmaceuticals Company Summary
Table 35. Bellicum Pharmaceuticals Engineered T Cells Product Offerings
Table 36. Bellicum Pharmaceuticals Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 37. Bellicum Pharmaceuticals Key News & Latest Developments
Table 38. Cells Medica Company Summary
Table 39. Cells Medica Engineered T Cells Product Offerings
Table 40. Cells Medica Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 41. Cells Medica Key News & Latest Developments
Table 42. Elli Lilly and Company Company Summary
Table 43. Elli Lilly and Company Engineered T Cells Product Offerings
Table 44. Elli Lilly and Company Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 45. Elli Lilly and Company Key News & Latest Developments
Table 46. Gilead Sciences Company Summary
Table 47. Gilead Sciences Engineered T Cells Product Offerings
Table 48. Gilead Sciences Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 49. Gilead Sciences Key News & Latest Developments
Table 50. Juno Therapeutics Company Summary
Table 51. Juno Therapeutics Engineered T Cells Product Offerings
Table 52. Juno Therapeutics Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 53. Juno Therapeutics Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Engineered T Cells Product Offerings
Table 56. Novartis Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Oxford Biomedica Company Summary
Table 59. Oxford Biomedica Engineered T Cells Product Offerings
Table 60. Oxford Biomedica Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 61. Oxford Biomedica Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Engineered T Cells Product Offerings
Table 64. Pfizer Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Precision Bioscience Company Summary
Table 67. Precision Bioscience Engineered T Cells Product Offerings
Table 68. Precision Bioscience Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 69. Precision Bioscience Key News & Latest Developments
Table 70. Redmile Group Company Summary
Table 71. Redmile Group Engineered T Cells Product Offerings
Table 72. Redmile Group Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 73. Redmile Group Key News & Latest Developments
Table 74. Seeking Alpha Company Summary
Table 75. Seeking Alpha Engineered T Cells Product Offerings
Table 76. Seeking Alpha Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 77. Seeking Alpha Key News & Latest Developments
Table 78. Unum Therapeutics Company Summary
Table 79. Unum Therapeutics Engineered T Cells Product Offerings
Table 80. Unum Therapeutics Engineered T Cells Revenue (US$, Mn) & (2018-2023)
Table 81. Unum Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Engineered T Cells Segment by Type in 2022
Figure 2. Engineered T Cells Segment by Application in 2022
Figure 3. Global Engineered T Cells Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Engineered T Cells Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Engineered T Cells Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Engineered T Cells Revenue in 2022
Figure 8. By Type - Global Engineered T Cells Revenue Market Share, 2018-2032
Figure 9. By Application - Global Engineered T Cells Revenue Market Share, 2018-2032
Figure 10. By Type - Global Engineered T Cells Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Engineered T Cells Revenue Market Share, 2018-2032
Figure 12. By Application - Global Engineered T Cells Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Engineered T Cells Revenue Market Share, 2018-2032
Figure 14. By Region - Global Engineered T Cells Revenue Market Share, 2018-2032
Figure 15. By Country - North America Engineered T Cells Revenue Market Share, 2018-2032
Figure 16. US Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Engineered T Cells Revenue Market Share, 2018-2032
Figure 20. Germany Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 21. France Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Engineered T Cells Revenue Market Share, 2018-2032
Figure 28. China Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 32. India Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Engineered T Cells Revenue Market Share, 2018-2032
Figure 34. Brazil Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Engineered T Cells Revenue Market Share, 2018-2032
Figure 37. Turkey Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Engineered T Cells Revenue, (US$, Mn), 2018-2032
Figure 41. Autolus Limited Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bellicum Pharmaceuticals Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Cells Medica Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Elli Lilly and Company Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Gilead Sciences Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Juno Therapeutics Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Oxford Biomedica Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Precision Bioscience Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Redmile Group Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Seeking Alpha Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Unum Therapeutics Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
